REFERENCES
- JOHNSON JW, ASHER P: Nature (1987) 385: 529-531.
- MCBRAIN CJ, KLECKNER NW, WYIUCK S. DINGLEDINE R: MoL PharmacoL (1989) 36: 556-565.
- HOOD WF, COMPTON RP, MONAHAN JB: Neurosc. Let. (1989) 98: 91-95.
- LEESON DL, BAKER R, CARLING RW, CURTIS NR, MOORE KW, WILLIAMS BJ, FOSTER AC, DONALD AE, KEMP JA, MARSHALL OR: J. Med. Chem. (1991) 34: 1243-1252.
- HUETTNER JE: Science (1989) 245: 1611-1613.
- WATJEN F, NIELSEN EO, DREIER J, JENSEN LH: Bioorg. Med. Chem. Let. (1993) 3: 105-106.
- LESTER RAJ, QUARUM ML, PARKER JD, WEBER E, JAHR CE: Mol. Pharm. (1989) 35: 565-570.
- SHEARDOWN MJ NIELSEN EO, HANSEN AJ, JACOBSEN P, HONORE T: Science (1990) 247: 571-572.
- KAWASAKI S, YATSUGI SI, TAKAHASHI M, KATOH M, KASHIYA K, SAKAMOTO S: Jpn. J. Phar-macoL (1993) 61(Suppl 1): 284P.
- RANDLE JCR, GUET T, BOBICHON C, MOREAU C, CURUTCHET P. LAMBOLEZ B, PRADO DE CARVALHO L, CORD: A, LEPAGNOL 3M: Mol. Pharmacol. (1992) 41: 337-345.
- Novo NORDISK AS, US5166155.
- ELI LILLY & Co, US5153196.
- Novo NoRriisx AS, W09306103-A1.
- ELI LILLY & Co, US5196421.
- SANDOZ LTD, EP-488959-A2.